NCT01031108 A Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT01031082 Study to Identify and Characterize Bacteria Causing Acute Otitis Media in South African Children Status COMPLETED Phase N/A
NCT01031069 Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females Status COMPLETED Phase PHASE4
NCT01030939 Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers Status COMPLETED Phase PHASE1
NCT01029015 Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects Status COMPLETED Phase N/A
NCT01027845 Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children Status COMPLETED Phase PHASE3
NCT01027598 Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01026064 Cantharidin-induced Skin Blister for Testing Anti-inflammatory Effects of Macrolides Status COMPLETED Phase PHASE1
NCT01021553 A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation Status COMPLETED Phase PHASE2
NCT01021293 Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine Status COMPLETED Phase PHASE3
NCT01019603 A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris Status COMPLETED Phase PHASE1
NCT01018628 A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2379 in Normal Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT01018186 Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study Status COMPLETED Phase PHASE3
NCT01018030 Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute Rhinosinusitis Status COMPLETED Phase PHASE2
NCT01018017 A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT01017952 A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3